197 related articles for article (PubMed ID: 23838369)
1. Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy.
Kuchař L; Asfaw B; Poupětová H; Honzíková J; Tureček F; Ledvinová J
Clin Chim Acta; 2013 Oct; 425():153-9. PubMed ID: 23838369
[TBL] [Abstract][Full Text] [Related]
2. Characterization of urinary sulfatides in metachromatic leukodystrophy using electrospray ionization-tandem mass spectrometry.
Whitfield PD; Sharp PC; Johnson DW; Nelson P; Meikle PJ
Mol Genet Metab; 2001 May; 73(1):30-7. PubMed ID: 11350180
[TBL] [Abstract][Full Text] [Related]
3. Quantification of sulfatides in dried blood and urine spots from metachromatic leukodystrophy patients by liquid chromatography/electrospray tandem mass spectrometry.
Barcenas M; Suhr TR; Scott CR; Turecek F; Gelb MH
Clin Chim Acta; 2014 Jun; 433():39-43. PubMed ID: 24370383
[TBL] [Abstract][Full Text] [Related]
4. Sulfatide Analysis by Mass Spectrometry for Screening of Metachromatic Leukodystrophy in Dried Blood and Urine Samples.
Spacil Z; Babu Kumar A; Liao HC; Auray-Blais C; Stark S; Suhr TR; Scott CR; Turecek F; Gelb MH
Clin Chem; 2016 Jan; 62(1):279-86. PubMed ID: 26585924
[TBL] [Abstract][Full Text] [Related]
5. Quantification of plasma sulfatides by mass spectrometry: Utility for metachromatic leukodystrophy.
Saville JT; Smith NJ; Fletcher JM; Fuller M
Anal Chim Acta; 2017 Feb; 955():79-85. PubMed ID: 28088283
[TBL] [Abstract][Full Text] [Related]
6. Ultra-performance liquid chromatography/tandem mass spectrometry for determination of sulfatides in dried blood spots from patients with metachromatic leukodystrophy.
Han M; Jun SH; Song SH; Park HD; Park KU; Song J
Rapid Commun Mass Spectrom; 2014 Mar; 28(6):587-94. PubMed ID: 24519821
[TBL] [Abstract][Full Text] [Related]
7. Human urinary sulfatides in patients with sulfatidosis (metachromatic leukodystrophy).
Philippart M; Sarlieve L; Meurant C; Mechler L
J Lipid Res; 1971 Jul; 12(4):434-41. PubMed ID: 5164093
[TBL] [Abstract][Full Text] [Related]
8. Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography-tandem mass spectrometry.
Mirzaian M; Kramer G; Poorthuis BJ
J Lipid Res; 2015 Apr; 56(4):936-43. PubMed ID: 25632048
[TBL] [Abstract][Full Text] [Related]
9. Sulfogalactosylceramides in motor and psycho-cognitive adult metachromatic leukodystrophy: relations between clinical, biochemical analysis and molecular aspects.
Colsch B; Afonso C; Turpin JC; Portoukalian J; Tabet JC; Baumann N
Biochim Biophys Acta; 2008 Mar; 1780(3):434-40. PubMed ID: 17980709
[TBL] [Abstract][Full Text] [Related]
10. Elevated sulfatide excretion in heterozygotes of metachromatic leukodystrophy: dependence on reduction of arylsulfatase A activity.
Molzer B; Sundt-Heller R; Kainz-Korschinsky M; Zobel M
Am J Med Genet; 1992 Nov; 44(4):523-6. PubMed ID: 1359786
[TBL] [Abstract][Full Text] [Related]
11. Urine sulfatides and the diagnosis of metachromatic leukodystrophy.
Natowicz MR; Prence EM; Chaturvedi P; Newburg DS
Clin Chem; 1996 Feb; 42(2):232-8. PubMed ID: 8595716
[TBL] [Abstract][Full Text] [Related]
12. Synthetic sulfogalactosylceramide (sulfatide) and its use for the mass spectrometric quantitative urinary determination in metachromatic leukodystrophies.
Cui Y; Colsch B; Afonso C; Baumann N; Tabet JC; Mallet JM; Zhang Y
Glycoconj J; 2008 Feb; 25(2):147-55. PubMed ID: 17701343
[TBL] [Abstract][Full Text] [Related]
13. Determination of urinary sulfatides and other lipids by combination of reversed-phase and thin-layer chromatographies.
Berná L; Asfaw B; Conzelmann E; Cerný B; Ledvinová J
Anal Biochem; 1999 May; 269(2):304-11. PubMed ID: 10222002
[TBL] [Abstract][Full Text] [Related]
14. Analysis of fatty acids and sphingosines from urinary sulfatides in a patient with metachromatic leukodystrophy by gas chromatography-mass spectrometry.
Nishio H; Kodama S; Matsuo T
Brain Dev; 1985; 7(6):614-21. PubMed ID: 3832951
[TBL] [Abstract][Full Text] [Related]
15. Biochemical profiling to predict disease severity in metachromatic leukodystrophy.
Tan MA; Fuller M; Zabidi-Hussin ZA; Hopwood JJ; Meikle PJ
Mol Genet Metab; 2010 Feb; 99(2):142-8. PubMed ID: 19815439
[TBL] [Abstract][Full Text] [Related]
16. HPLC analysis of urinary sulfatide: an aid in the diagnosis of metachromatic leukodystrophy.
Strasberg PM; Warren I; Skomorowski MA; Lowden JA
Clin Biochem; 1985 Apr; 18(2):92-7. PubMed ID: 2861921
[TBL] [Abstract][Full Text] [Related]
17. Elevated sulfatide excretion in compound heterozygotes of metachromatic leukodystrophy and ASA-pseudodeficiency allele.
Lugowska A; Tylki-Szymańska A; Berger J; Molzer B
Clin Biochem; 1997 Jun; 30(4):325-31. PubMed ID: 9209791
[TBL] [Abstract][Full Text] [Related]
18. Measurement of sulfatides in the amniotic fluid supernatant: A useful tool in the prenatal diagnosis of metachromatic leukodystrophy.
Kubaski F; Herbst ZM; Burin MG; Michelin-Tirelli K; Trapp FB; Gus R; Netto ABO; Brusius-Facchin AC; Leistner-Segal S; Sanseverino MT; de Souza CMF; Wilke MVMB; Oliveira T; Magalhães JAA; Giugliani R
JIMD Rep; 2022 Mar; 63(2):162-167. PubMed ID: 35281662
[TBL] [Abstract][Full Text] [Related]
19. Higher precision, first tier newborn screening for metachromatic leukodystrophy using 16:1-OH-sulfatide.
Bekri S; Bley A; Brown HA; Chanson C; Church HJ; Gelb MH; Hong X; Janzen N; Kasper DC; Mechtler T; Morton G; Murko S; Oliva P; Tebani A; Wu THY
Mol Genet Metab; 2024 May; 142(1):108436. PubMed ID: 38552449
[TBL] [Abstract][Full Text] [Related]
20. Distribution of C16:0, C18:0, C24:1, and C24:0 sulfatides in central nervous system lipid rafts by quantitative ultra-high-pressure liquid chromatography tandem mass spectrometry.
Moyano AL; Li G; Lopez-Rosas A; Månsson JE; van Breemen RB; Givogri MI
Anal Biochem; 2014 Dec; 467():31-9. PubMed ID: 25205652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
